- Home
- ARVN vs IDR Comparison
ARVN vs IDR Comparison
Compare ARVN & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARVN | IDR |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 671.6M |
| IPO Year | 2018 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ARVN | IDR |
|---|---|---|
| Price | $10.13 | $27.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 1 |
| Target Price | $15.35 | ★ $17.50 |
| AVG Volume (30 Days) | ★ 670.7K | 260.7K |
| Earning Date | 04-30-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 58.84 | ★ 70.15 |
| EPS | N/A | ★ 1.14 |
| Revenue | ★ $262,600,000.00 | $42,406,253.00 |
| Revenue This Year | N/A | $17.18 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $23.11 |
| Revenue Growth | N/A | ★ 64.59 |
| 52 Week Low | $5.90 | $12.25 |
| 52 Week High | $14.22 | $54.70 |
Technical Indicators
Market Signals| Indicator | ARVN | IDR |
|---|---|---|
| Relative Strength Index (RSI) | 31.91 | 33.48 |
| Support Level | $9.02 | $22.31 |
| Resistance Level | $10.18 | $28.56 |
| Average True Range (ATR) | 0.67 | 2.15 |
| MACD | -0.22 | -0.73 |
| Stochastic Oscillator | 4.18 | 8.99 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.